Beta Bionics (BBNX) Shares Outstanding (2023 - 2026)
Beta Bionics (BBNX) posted Shares Outstanding (Entity) of $45.0 million for Q2 2026, up 0.94% sequentially from $44.6 million in Q1 2026, and up 3.49% YoY from $43.5 million in Q2 2025.
Beta Bionics (BBNX) Shares Outstanding (2023 - 2026) Analysis & Trends
Beta Bionics has reported Shares Outstanding (Entity) for 4 years, with the latest figure at $45.0 million in Q2 2026.
- Quarterly Shares Outstanding (Entity) rose 3.49% year-over-year to $45.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $45.0 million (up 3.49% YoY) and the FY2025 annual result came in at $44.4 million, up 565.3% from the prior year.
- Shares Outstanding (Entity) grew to $45.0 million in Q2 2026 per BBNX's latest filing, from $44.6 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $45.0 million in Q2 2026 and troughed at $6.0 million in Q4 2023.
- A 4-year average of $25.8 million and a median of $30.7 million in 2025 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) soared 565.3% in 2025, then increased 3.49% in 2026.
- Over 4 years, Shares Outstanding (Entity) stood at $6.0 million in 2023, then advanced by 10.74% to $6.7 million in 2024, then jumped by 565.3% to $44.4 million in 2025, then advanced by 1.4% to $45.0 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $45.0 million, $44.6 million, and $44.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Beta Bionics | 840.57 Mn | 660.08 Mn | 18.90 Mn | 44.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.55 Mn |
| Mar 31, 2026 | 44.44 Mn |
| Dec 31, 2025 | 40.53 Mn |
| Sep 30, 2025 | 43.63 Mn |
| Jun 30, 2025 | 43.39 Mn |
| Mar 31, 2025 | 30.71 Mn |
| Dec 31, 2024 | 6.37 Mn |
| Sep 30, 2024 | 6.66 Mn |
| Jun 30, 2024 | 6.11 Mn |
| Mar 31, 2024 | 6.02 Mn |
| Dec 31, 2023 | 5.30 Mn |